BAY 1135626 - CAS 1404071-37-9

BAY 1135626 synthesizes BAY 1129980, an Auristatin-based anti-C4.4A (LYPD3) antibody–drug conjugate (ADC) used in non–small cell lung cancer (NSCLC) research and anti-tumor studies [1].

Drug-Linker Conjugates for ADC

Antibody-drug Conjugate/ADC Related

1404071-37-9

C55H86N10O11

1063.33

C([C@H](NC([C@@H]([C@@H](OC)[C@]1(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(CCCC(NNC(CCCCCN2C(=O)C=CC2=O)=O)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC1)[H])C)=O)C(N)=O)C=3C=4C(NC3)=CC=CC4

-20°C

Ice Packs

Small Compound